Market Overview

Officers, Directors and Merger Details

Share:

CHEYENNE, WY / ACCESSWIRE / June 18, 2019 / THERAPY CELLS, INC. (OTC:TCEL) Therapy Cells, Inc. has been unsuccessful in raising the required capital to pursue the FDA approval of the growing of Tendon and Articular cartilage for autotransplantation into humans. Their rights to the patents have expired. They are excited to have received Board and Shareholder approval to go forward with a merger of Therapy Cells Inc. and XTRA Bitcoin Inc of Fruitland, Idaho. TCEL has elected new directors and appointed new officers to facilitate the merger which is expected to be completed in the third quarter of 2019.

Paul Knudson, Jacob Veatch, and Matthew Timpson were elected as Directors. Officers are: Paul Knudson, President, Mary A Veatch, Secretary, and Gregory Knudson, Treasurer.

XTRA Bitcoin Inc (XTRA) was created on December 11, 2017 by conversion of JR Development LLC, (an Idaho LLC formed December 22, 2005)in anticipation of merging its developing crypto-mining business with Xtra Energy Corporation (XTPT). XTRA commenced bitcoin mining in March 2018. When that proposed merger did not come to fruition, XTRA's crypto-mining assets were divested on May 31, 2018 to form affiliate Xtra Crypto Mining Inc. and divested its residential subdivision development land to affiliate The Pines Townhomes LLC on July 9, 2018.

XTRA Bitcoin Inc's president, Paul Knudson, will oversee the merger with TCEL and manage the development of its bitcoin mining business as a publicly trading company. XTRA leased facilities with 2MW of electrical capacity on June 1, 2019 and is seeking funding for acquisition of new ASIC mining equipment, electrical infrastructure, and installation.

If you would like more information about this topic, please call Paul Knudson at 1-208-630-6678, or email paul@xtrabitcoin.com.

CONTACT:

Paul Knudson, President
208-630-6678
paul@xtrabitcoin.com

SOURCE: XTRA Bitcoin, Inc

View source version on accesswire.com:
https://www.accesswire.com/549116/Officers-Directors-and-Merger-Details

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com